Examples of using Mechanism of interaction in English and their translations into Greek
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Official/political
-
Computer
Mechanism of interaction.
Medicinal product[Mechanism of Interaction].
(mechanism of interaction unknown).
Medicinal Product/ Possible Mechanism of Interaction.
Mechanism of interaction.
Medicinal product by therapeutic areas/Possible Mechanism of Interaction.
Cmax:↑ 64%(mechanism of interaction unknown).
Mechanism of interaction is CYP3A4 inhibition by fosamprenavir/ritonavir.
Norbuprenorphine↑ 2.05↑ 1.61↑ 2.01 The mechanism of interaction is CYP3A4 and UGT1A1 inhibition.
The mechanism of interaction is CYP3A4 inhibition.
The mechanism of interaction is unknown.
The mechanism of interaction is CYP3A4 induction by etravirine.
The mechanism of interaction is CYP3A4 and UGT1A1 inhibition.
The mechanism of interaction is CYP3A induction by the antiepileptic.
The mechanism of interaction is inhibition of P-gp by cobicistat.
The mechanism of interaction is CYP3A4 induction by rifampicin.
The mechanism of interaction is inhibition of metabolism by atazanavir.
The mechanism of interaction is inhibition of CYP2D6 by cobicistat.
The mechanism of interaction between atazanavir and tenofovir is unknown.
The mechanism of interaction is P-gp inhibition by atazanavir and cobicistat.
The mechanism of interaction is CYP3A4 inhibition by atazanavir/ritonavir.
The mechanism of interaction is CYP3A4 inhibition by atazanavir and/or ritonavir.
The mechanism of interaction is CYP3A4 and UGT1A1 inhibition by atazanavir.
The mechanism of interaction between the infecting organism and the host is unknown.
The mechanism of interaction between atazanavir and tenofovir disoproxil fumarate is unknown.
The mechanism of interaction is inhibition of CYP3A4 and/or CYP2D6 by atazanavir and/or cobicistat.
The mechanism of interaction between efavirenz and atazanavir, or efavirenz and cobicistat is CYP3A4 induction by efavirenz.
The mechanism of interaction is decreased solubility of atazanavir as intra- gastric pH increases with H2 blockers.
The mechanism of interaction could possibly be due to an initial inhibition and subsequent induction of transport proteins.
The mechanism of interaction is decreased solubility of atazanavir as intra-gastric pH increases with H2-blockers.